These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
284 related items for PubMed ID: 28850686
21. Estrogen receptor α-NOTCH1 axis enhances basal stem-like cells and epithelial-mesenchymal transition phenotypes in prostate cancer. Shen Y, Cao J, Liang Z, Lin Q, Wang J, Yang X, Zhang R, Zong J, Du X, Peng Y, Zhang J, Shi J. Cell Commun Signal; 2019 May 23; 17(1):50. PubMed ID: 31122254 [Abstract] [Full Text] [Related]
22. Metformin inhibits 17β-estradiol-induced epithelial-to-mesenchymal transition via βKlotho-related ERK1/2 signaling and AMPKα signaling in endometrial adenocarcinoma cells. Liu Z, Qi S, Zhao X, Li M, Ding S, Lu J, Zhang H. Oncotarget; 2016 Apr 19; 7(16):21315-31. PubMed ID: 26824324 [Abstract] [Full Text] [Related]
23. Insulin exacerbated high glucose-induced epithelial-mesenchymal transition in prostatic epithelial cells BPH-1 and prostate cancer cells PC-3 via MEK/ERK signaling pathway. Yang T, Zhou Y, Wang H, Chen S, Shen M, Hu Y, Wang T, Liu J, Jiang Z, Wang Z, Zhu X, Qian S, Yin X, Lu Q. Exp Cell Res; 2020 Sep 01; 394(1):112145. PubMed ID: 32561286 [Abstract] [Full Text] [Related]
24. Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation. Lau KM, LaSpina M, Long J, Ho SM. Cancer Res; 2000 Jun 15; 60(12):3175-82. PubMed ID: 10866308 [Abstract] [Full Text] [Related]
25. Effect of benzophenone-1 and octylphenol on the regulation of epithelial-mesenchymal transition via an estrogen receptor-dependent pathway in estrogen receptor expressing ovarian cancer cells. Shin S, Go RE, Kim CW, Hwang KA, Nam KH, Choi KC. Food Chem Toxicol; 2016 Jul 15; 93():58-65. PubMed ID: 27145024 [Abstract] [Full Text] [Related]
27. Estrogen regulates Snail and Slug in the down-regulation of E-cadherin and induces metastatic potential of ovarian cancer cells through estrogen receptor alpha. Park SH, Cheung LW, Wong AS, Leung PC. Mol Endocrinol; 2008 Sep 15; 22(9):2085-98. PubMed ID: 18550773 [Abstract] [Full Text] [Related]
29. The therapeutic effects of docosahexaenoic acid on oestrogen/androgen-induced benign prostatic hyperplasia in rats. Wang C, Luo F, Zhou Y, Du X, Shi J, Zhao X, Xu Y, Zhu Y, Hong W, Zhang J. Exp Cell Res; 2016 Jul 15; 345(2):125-33. PubMed ID: 25849092 [Abstract] [Full Text] [Related]
30. Potential ameliorative effects of epigallocatechin‑3‑gallate against testosterone-induced benign prostatic hyperplasia and fibrosis in rats. Zhou J, Lei Y, Chen J, Zhou X. Int Immunopharmacol; 2018 Nov 15; 64():162-169. PubMed ID: 30179845 [Abstract] [Full Text] [Related]
31. Estradiol agonists inhibit human LoVo colorectal-cancer cell proliferation and migration through p53. Hsu HH, Kuo WW, Ju DT, Yeh YL, Tu CC, Tsai YL, Shen CY, Chang SH, Chung LC, Huang CY. World J Gastroenterol; 2014 Nov 28; 20(44):16665-73. PubMed ID: 25469035 [Abstract] [Full Text] [Related]
32. Lipoxin A4 Suppresses Estrogen-Induced Epithelial-Mesenchymal Transition via ALXR-Dependent Manner in Endometriosis. Wu RF, Huang ZX, Ran J, Dai SJ, Lin DC, Ng TW, Chen QX, Chen QH. Reprod Sci; 2018 Apr 28; 25(4):566-578. PubMed ID: 28691579 [Abstract] [Full Text] [Related]
33. Epithelial-mesenchymal transition in prostatic disease. Broster SA, Kyprianou N. Future Oncol; 2015 Apr 28; 11(23):3197-206. PubMed ID: 26551285 [Abstract] [Full Text] [Related]
34. A role for epithelial-mesenchymal transition in the etiology of benign prostatic hyperplasia. Alonso-Magdalena P, Brössner C, Reiner A, Cheng G, Sugiyama N, Warner M, Gustafsson JA. Proc Natl Acad Sci U S A; 2009 Feb 24; 106(8):2859-63. PubMed ID: 19196965 [Abstract] [Full Text] [Related]
35. MIR663AHG as a competitive endogenous RNA regulating TGF-β-induced epithelial proliferation and epithelial-mesenchymal transition in benign prostate hyperplasia. Tong S, Mo M, Hu X, Wu L, Chen M, Zhao C. J Biochem Mol Toxicol; 2023 Sep 24; 37(9):e23391. PubMed ID: 37518988 [Abstract] [Full Text] [Related]
36. Membrane-initiated estrogen signaling in prostate cancer: A route to epithelial-to-mesenchymal transition. Gadkar S, Nair S, Patil S, Kalamani S, Bandivdekar A, Patel V, Chaudhari U, Sachdeva G. Mol Carcinog; 2019 Nov 24; 58(11):2077-2090. PubMed ID: 31411358 [Abstract] [Full Text] [Related]
37. The exosome-like vesicles derived from androgen exposed-prostate stromal cells promote epithelial cells proliferation and epithelial-mesenchymal transition. Chen J, Rong N, Liu M, Xu C, Xiong Q, Lei Y. Toxicol Appl Pharmacol; 2021 Jan 15; 411():115384. PubMed ID: 33359661 [Abstract] [Full Text] [Related]
38. Estrogens activate bone morphogenetic protein-2 gene transcription in mouse mesenchymal stem cells. Zhou S, Turgeman G, Harris SE, Leitman DC, Komm BS, Bodine PV, Gazit D. Mol Endocrinol; 2003 Jan 15; 17(1):56-66. PubMed ID: 12511606 [Abstract] [Full Text] [Related]
39. Traditional Chinese Medicine Danzhi qing'e decoction inhibits inflammation-associated prostatic hyperplasia via inactivation of ERK1/2 signal pathway. Liu Y, Shao R, Suo T, Zhu J, Liu E, Wang Y, Miao L, Gao X. J Ethnopharmacol; 2023 Jun 12; 309():116354. PubMed ID: 36906158 [Abstract] [Full Text] [Related]
40. Adiponectin as a potential tumor suppressor inhibiting epithelial-to-mesenchymal transition but frequently silenced in prostate cancer by promoter methylation. Tan W, Wang L, Ma Q, Qi M, Lu N, Zhang L, Han B. Prostate; 2015 Aug 01; 75(11):1197-205. PubMed ID: 25877612 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]